Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11951
PUT
Babcock & Wilcox
BW
$1.17B
| $37.4K | ﹤0.01% |
55,800
+27,200
| +95% | +$33.6K |
|
|
GBIO
11952
DELISTED
Generation Bio
GBIO
| $37.4K | ﹤0.01% |
9,225
+6,946
| +305% | +$48.8K |
|
|
TOUR
11953
Tuniu
TOUR
$52.6M
| $37.2K | ﹤0.01% |
3,384
-2,992
| -47% | -$30.8K |
|
11954
Offerpad Solutions
OPAD
$21.5M
| $37.2K | ﹤0.01% |
+2,242
| New | +$48.8K |
|
11955
AirSculpt Technologies
AIRS
$192M
| $37.1K | ﹤0.01% |
+15,883
| New | +$71.3K |
|
|
CAPT
11956
PUT
DELISTED
Captivision
CAPT
| $37.1K | ﹤0.01% |
+78,900
| New | +$42.5K |
|
11957
PUT
Immunic
IMUX
$224M
| $37K | ﹤0.01% |
3,390
-14,070
| -81% | -$152K |
|
|
BQ
11958
Boqii Holding Ltd
BQ
$6.94M
| $36.9K | ﹤0.01% |
+17,415
| New | +$52.2K |
|
11959
DB Gold Double Short ETN due Feb 15 2038
DZZ
$2.88M
| $36.9K | ﹤0.01% |
22,629
-6,874
| -23% | -$11.3K |
|
11960
Metalpha Technology Holding
MATH
$37M
| $36.8K | ﹤0.01% |
21,670
-68,410
| -76% | -$121K |
|
|
SLI
11961
CALL
Standard Lithium
SLI
$634M
| $36.8K | ﹤0.01% |
29,000
-394,700
| -93% | -$572K |
|
11962
PUT
Diana Shipping
DSX
$342M
| $36.8K | ﹤0.01% |
23,600
+4,800
| +26% | +$8.71K |
|
11963
PUT
Ocean Power Technologies
OPTT
$50.3M
| $36.3K | ﹤0.01% |
79,000
-118,500
| -60% | -$85.2K |
|
|
TAIT
11964
DELISTED
Taitron Components
TAIT
| $36.3K | ﹤0.01% |
14,414
-1,088
| -7% | -$2.81K |
|
|
GAU
11965
PUT
Galiano Gold
GAU
$628M
| $36K | ﹤0.01% |
29,000
+18,000
| +164% | +$22.1K |
|
11966
CALL
Black Diamond Therapeutics
BDTX
$129M
| $35.6K | ﹤0.01% |
+23,000
| New | +$48.2K |
|
|
RJET
11967
Republic Airways Holdings
RJET
$897M
| $35.6K | ﹤0.01% |
+3,032
| New | +$51.8K |
|
11968
Gaotu Techedu
GOTU
$410M
| $35.6K | ﹤0.01% |
+10,940
| New | +$30.2K |
|
11969
Harvard Bioscience
HBIO
$34.5M
| $35.6K | ﹤0.01% |
6,281
+2,735
| +77% | +$35K |
|
11970
CALL
ProQR Therapeutics
PRQR
$336M
| $35.2K | ﹤0.01% |
26,500
+16,100
| +155% | +$34.3K |
|
11971
PUT
Smart Sand
SND
$199M
| $35.2K | ﹤0.01% |
+13,600
| New | +$31.9K |
|
|
BOLD
11972
Boundless Bio
BOLD
$66.9M
| $35.1K | ﹤0.01% |
+23,243
| New | +$48.2K |
|
|
AMRN
11973
CALL
Amarin Corp
AMRN
$299M
| $34.8K | ﹤0.01% |
3,865
-455
| -11% | -$4.82K |
|
|
CSCI
11974
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
| $34.6K | ﹤0.01% |
+11,907
| New | +$35.1K |
|
|
NEWP
11975
New Pacific Metals
NEWP
$1.31B
| $34.5K | ﹤0.01% |
31,225
-7,478
| -19% | -$8.89K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,482 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.